For: | Guo Z, Wang J, Li L, Liu R, Fang J, Tie B. Value of miR-1271 and glypican-3 in evaluating the prognosis of patients with hepatocellular carcinoma after transcatheter arterial chemoembolization. World J Clin Cases 2020; 8(16): 3493-3502 [PMID: 32913856 DOI: 10.12998/wjcc.v8.i16.3493] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v8/i16/3493.htm |
Number | Citing Articles |
1 |
Jinying Zhao, Yanhua Wang, Huahua Su, Lijia Su. Non-coding RNAs as biomarkers for hepatocellular carcinoma—A systematic review. Clinics and Research in Hepatology and Gastroenterology 2021; 45(6): 101736 doi: 10.1016/j.clinre.2021.101736
|
2 |
Aurora NICOLOSI, Silvia GAIA, Alessandra RISSO, Chiara ROSSO, Emanuela ROLLE, Maria L. ABATE, Antonella OLIVERO, Angelo ARMANDI, Davide G. RIBALDONE, Patrizia CARUCCI, Sharmila FAGOONEE, Rinaldo PELLICANO, Giorgio M. SARACCO, Elisabetta BUGIANESI, Gian P. CAVIGLIA. Serum glypican-3 for the prediction of survival in patients with hepatocellular carcinoma. Minerva Gastroenterology 2022; 68(4) doi: 10.23736/S2724-5985.21.03006-0
|
3 |
Alessandro Marco Bozzato, Paola Martingano, Roberta Antea Pozzi Mucelli, Marco Francesco Maria Cavallaro, Matteo Cesarotto, Cristina Marcello, Claudio Tiribelli, Devis Pascut, Riccardo Pizzolato, Fabio Pozzi Mucelli, Mauro Giuffrè, Lory Saveria Crocè, Maria Assunta Cova. MicroRNAs Related to TACE Treatment Response: A Review of the Literature from a Radiological Point of View. Diagnostics 2022; 12(2): 374 doi: 10.3390/diagnostics12020374
|